|
WO2020253753A1
|
|
Method for repairing abnormal splicing of intron, product and use
|
|
WO2020187272A1
|
|
Fusion protein for gene therapy and application thereof
|
|
CN110386941A
|
|
EP4 receptor antagonist and PD-1 inhibitor joint are used for the treatment of cancer
|
|
CN111840544A
|
|
Application of defucose anti-HER 2 antibody in cancer patient carrying Fc gamma R2A131R genotype
|
|
WO2019086007A1
|
|
Sgrna for targeting and guiding cas9 protein to efficiently cleave tcr and b2m gene loci
|
|
CN112125974A
|
|
Antibodies targeting BCMA proteins, chimeric antigen receptors and drugs
|
|
CN110339364A
|
|
LGR4/RSPO blocking agent combines the immunization therapy for tumour with anti-immunity checkpoint inhibitor
|
|
CN109836434A
|
|
Thieno cyclics and its synthetic method and application
|
